Counseling requirements for buprenorphine maintenance in primary care: Lessons learned from a preliminary study in a methadone maintenance program

Addictive Disorders and their Treatment

Volumn 3, Issue 2, 2004, Pages 71-76

  Pantalon, Michael V ^a   Fiellin, David A ^a   O'Connor, Patrick G ^a   Chawarski, Marek C ^a   Pakes, Juliana R ^b   Schottenfeld, Richard S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Buprenorphine; Drug counseling; Nurses; Opioid dependence; Primary care

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; METHADONE TREATMENT; NURSE; OPIATE ADDICTION; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 2942582362     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132576-200406000-00003     Document Type: Article

References (13)

1. Fiellin DA, O'Connor PG. New Federal initiatives to enhance the medical treatment of opioid dependence. Ann Intern Med. 2002;137:688-692.
2. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998; 280:1936-1943. Available online at http://odp.od.nih.gov/consensus/cons/108/108_intro.htm.
3. Office of National Drug Control Policy. Policy Paper: Opioid Agonist Treatment. Washington, D.C.: Executive Office of the President, Office of National Drug Control Policy; 1999.
4. McLellan AT, Arndt IO, Metzger DS, et al. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1943-1959.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: Author; 1994.
6. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-IV. Washington, DC: American Psychiatric Press; 1995.
7. Fawcett J, Epstein P, Fiester SJ, et al. Clinical management-imipramine/placebo administration manual NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull. 1987;23:309-324.
8. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, N.Y.: Guilford Press; 1991.
9. Daley D, Mercer D. Drug Counseling for Cocaine Addiction: The Collaborative Cocaine Treatment Study Model. Bethesda, MD: National Institute on Drug Abuse; 2002.
10. Crits-Christoph P, Siqueland L, Blaine J, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psych. 1999;56: 493-502.
11. Schottenfeld RS, Pakes JR, Oliveto A, et al. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psych. 1997;54:713-720.
12. Schottenfeld RS, Pantalon MV, Chawarski MC, et al. Efficacy of the community reinforcement approach for combined opioid and cocaine dependence: patterns of engagement in alternate activities. J Subst Abuse Treat. 2000;18:255-261.
13. Fiellin DA, Pantalon MY, Pakes JP, et al. Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse. 2002;28:231-241.